Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00351351 · ClinicalTrials.gov registry record · NA

Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy

A NA study of Kidney Stones, sponsored by Indiana Kidney Stone Institute.

Completed
Registry status
NA
Development phase
70
Enrollment target
7
Study locations

NCT00351351 is a NA study of Kidney Stones that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 70 participants, below the 290-participant average among 15 other Kidney Stones trials with a reported enrollment target (76% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00351351, a NA study of Kidney Stones, has completed, sponsored by Indiana Kidney Stone Institute.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
7
Study locations

Study Summary

Percutaneous nephrolithotomy (PNL), in conjunction with intracorporeal lithotripsy, allows for the rapid removal of any kidney stone regardless of size. Currently, the choice of intracorporeal lithotripters includes ultrasonic, pneumatic, and combined ultrasonic/pneumatic energy sources. Recently, a novel dual probe design as been introduced by Cybersonics of Erie, Pennsylvania. This dual probe intracorporeal lithotrite is called the Cyberwand, and is composed of a fixed inner probe vibrating at an ultrasonic frequency with an outer probe vibrating at about 1,000 Hz. As this new design has the potential to revolutionize intracorporeal lithotripsy, we intend to compare this novel technology to currently available lithotripsy technology in a randomized clinical trial.

Conditions Studied

Kidney Stones

Interventions

  • DEVICE Cyberwand
  • DEVICE single probe ultrasonic

Study Locations (7)

Illinois

  • Northwestern University Dept. of Urology - Chicago

Indiana

  • Methodist Hospital - Indianapolis

Maryland

  • John's Hopkins University - Baltimore

North Carolina

  • Duke University - Durham

Wisconsin

  • University of Wisconsin - Madison

British Columbia

  • Vancouver Hospital - Vancouver

Ontario

  • University of Western Ontario - St. Joseph's Hospital - London

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2006-07
Est. Completion 2008-05
Phase NA

Sponsor

Indiana Kidney Stone Institute

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00351351

The ClinicalTrials.gov registry entry for NCT00351351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 290-participant average among 15 other Kidney Stones trials with a reported enrollment target (76% lower). The listed sponsor is Indiana Kidney Stone Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Cyberwand is the first listed.

NCT00351351 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Illinois, Indiana, Maryland.

Frequently Asked Questions

What is clinical trial NCT00351351 about?

NCT00351351 is a clinical study titled "Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy". Percutaneous nephrolithotomy (PNL), in conjunction with intracorporeal lithotripsy, allows for the rapid removal of any kidney stone regardless of size. Currently, the choice of intracorporeal lithotripters includes ultrasonic, pneumatic, and combined ultrasonic/pneumatic energy sources. Recently, a...

What is the current status of trial NCT00351351?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2006-07. Estimated completion is 2008-05.

What conditions does trial NCT00351351 study?

This clinical trial studies the following conditions: Kidney Stones.

What interventions are being tested in trial NCT00351351?

The interventions under investigation include: Cyberwand (DEVICE), single probe ultrasonic (DEVICE).

Who is sponsoring clinical trial NCT00351351?

This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00351351 being conducted?

This trial has 7 study locations across Illinois, Indiana, Maryland, North Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Stones

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Stones

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.